Durin Technologies

Camden, United States Founded: 2010 • Age: 16 yrs
Developer of the diagnostic test for neurodegenerative diseases
Request Access

About Durin Technologies

Durin Technologies is a company based in Camden (United States) founded in 2010 by Benjamin Belinka and Robert Nagele.. Durin Technologies has raised $8.05 million across 3 funding rounds from investors including Breakthrough Diagnostics. Durin Technologies offers products and services including Duritect-AD™ and Duritect-PD™. Durin Technologies operates in a competitive market with competitors including Amprion, ADx NeuroSciences, PeopleBio R&D, Cytox and ALA Diagnostics, among others.

  • Headquarter Camden, United States
  • Founders Benjamin Belinka, Robert Nagele
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Durin Technologies, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.05 M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.5 M (USD), Debt – Conventional

    Oct 26, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Durin Technologies

Durin Technologies offers a comprehensive portfolio of products and services, including Duritect-AD™ and Duritect-PD™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Blood test for early assessment of Alzheimer's disease risk.

Blood test for early assessment of Parkinson's disease risk.

People of Durin Technologies
Headcount 1-10
Employee Profiles 2
Employee Profiles
People
Mert Sahin, PhD
Chief Executive Officer
People
Dennis Hutchison
Chief Strategy And Commercial Officer

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Durin Technologies

Durin Technologies has successfully raised a total of $8.05M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.5 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Debt – Conventional — $3.5M
  • First Round

    (17 Dec 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Debt – Conventional - Durin Technologies Valuation

investors

Dec, 2022 Amount Series B - Durin Technologies Valuation

investors

Dec, 2019 Amount Series A - Durin Technologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Durin Technologies

Durin Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Breakthrough Diagnostics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Durin Technologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Durin Technologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Durin Technologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Durin Technologies

Durin Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amprion, ADx NeuroSciences, PeopleBio R&D, Cytox and ALA Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
domain founded_year HQ Location
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
domain founded_year HQ Location
Immunoassays are developed for early detection of neurodegenerative diseases.
domain founded_year HQ Location
Prognostic tests for assessing dementia risk are developed.
domain founded_year HQ Location
In vitro diagnostic kits for multiple sclerosis detection are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Durin Technologies

Frequently Asked Questions about Durin Technologies

When was Durin Technologies founded?

Durin Technologies was founded in 2010 and raised its 1st funding round 9 years after it was founded.

Where is Durin Technologies located?

Durin Technologies is headquartered in Camden, United States.

Is Durin Technologies a funded company?

Durin Technologies is a funded company, having raised a total of $8.05M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.5M, raised on Dec 17, 2019.

What does Durin Technologies do?

Developer of the diagnostic test for neurodegenerative diseases. The test is based on the detection of disease-specific autoantibodies as blood biomarkers associated with Alzheimers and Parkinsons disease.

Who are the top competitors of Durin Technologies?

Durin Technologies's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.

What products or services does Durin Technologies offer?

Durin Technologies offers Duritect-AD™ and Duritect-PD™.

Who are Durin Technologies's investors?

Durin Technologies has 1 investor. Key investors include Breakthrough Diagnostics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available